Scientists at Scripps Research in La Jolla have demonstrated a promising new strategy for treating lymphomas, a group of cancers that begin in infection-fighting cells of the immune system called lymphocytes.
Scripps Research study uses modified ‘killer cells’ to defeat lymphoma while sparing healthy cells
Scientists at Scripps Research in La Jolla have demonstrated a promising new strategy for treating lymphomas, a group of cancers that begin in infection-fighting cells of the immune system called lymphocytes.